Naibedya Chattopadhyay is an expert in Biochemistry at Central Drug Research Institute (India). As of October 2026, ScienceLeadR ranks Naibedya Chattopadhyay in the top 1% of experts in India for Osteoporosis and Bone Diseases, Metabolic. Naibedya Chattopadhyay has authored 335 publications, the most recent in 2026. SLR score: 1,016 (community average: 125). How the SLR is computed.

LeadR Profile

Naibedya Chattopadhyay Central Drug Research Institute India
1 016 ScienceLeadR Reputation 1016
Network Map

Biochemistry

Subspecialties: Endocrinology - Pharmacy - Rheumatology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1993 - 2026

Source: PubMed

Central Drug Research Institute

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 335

Citations

Citations: 12 981 1st author: 32 Last author: 126 Unique author: 8


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Injectable polysaccharide-based composite hydrogel promotes regeneration of critical-sized bone defects.
PMID 42471203 — cytokines, hydrogel, polyethylene glycol dimethacrylate, hydrogels, growth, safety, polysaccharides, bone regeneration, therapeutics
Int J Biol Macromol20260
Phytochemicals Targeting Wnt/β-Catenin in Osteoblasts: Mechanisms, Scaffolds, and Computational Insights for Bone Therapeutics.
PMID 41940564 — triterpenes, genes, catenins, osteoblasts, pharmaceutical preparations, glycosides, osteoporosis, therapeutics, ligands, phytochemicals
Phytother Res20260
Analysis of metabolic rewiring in MDR1-overexpressing drug-resistant glioblastoma.
PMID 41993583 — cells, temozolomide, pharmaceutical preparations, metabolomics, glioblastoma, therapeutics
Front Pharmacol20260
Circadian rhythm-aligned time-restricted feeding prevents ovariectomy-induced fat gain, insulin resistance, and osteosarcopenia in rats.
PMID 41916467 — estrogens, insulin resistance, insulin, blood, circadian rhythm, ovariectomy
J Nutr20260
Heavy Metals as Accelerators of Dementia Progression: Evidence From a Stage-Specific Systematic Review and Meta-Analyses.
PMID 41802757 — dementia, blood, serum, toxicology
J Appl Toxicol20260

LeadR Networks

Main global connection map